CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 33 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-14 | Mehta Vimal CEO and President | Option exercise 10b5-1 | +2,609 | 46,173 | ||
| 2024-06-14 | Mehta Vimal CEO and President | Option exercise · Restricted Stock Units 10b5-1 | −2,609 | 18,266 | ||
| 2024-06-10 | Votruba Michal Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2024-06-10 | Votruba Michal Director | Other disposition · Stock Option (Right to Buy) | −17,000 | 0 | ||
| 2024-06-10 | Laumas Sandeep Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2024-06-10 | MUELLER PETER Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2024-06-10 | MILLER MICHAEL PATRICK Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2024-06-10 | Bray June Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2024-06-05 | Mehta Vimal CEO and President | Sale | −283,122 | 0 | ||
| 2024-06-05 | Mehta Vimal CEO and President | Sale | −126,014 | $1.58 | $200K | 7,685,501 |
| 2024-06-04 | Mehta Vimal CEO and President | Sale | −609,221 | 7,937,529 | ||
| 2024-06-04 | Mehta Vimal CEO and President | Sale | −283,123 | 283,122 | ||
| 2024-06-04 | Mehta Vimal CEO and President | Sale | −126,014 | $1.63 | $206K | 7,811,515 |
| 2024-06-04 | Mehta Vimal CEO and President | Sale · Call Options (obligation to sell) | −120 | 120 | ||
| 2024-04-04 | O'Neill Vincent See Remarks | Sale 10b5-1 | −165 | $2.62 | $432 | 5,408 |
| 2024-04-04 | Mehta Vimal CEO and President | Sale 10b5-1 | −829 | $2.62 | $2K | 48,003 |
| 2024-04-04 | Mehta Vimal CEO and President | Sale 10b5-1 | −4,439 | $2.62 | $12K | 43,564 |
| 2024-04-04 | Steinhart Richard I Chief Financial Officer | Sale 10b5-1 | −1,069 | $2.64 | $3K | 4,765 |
| 2024-04-04 | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −1,008 | $2.64 | $3K | 2,992 |
| 2024-04-04 | Rodriguez Javier See Remarks | Sale 10b5-1 | −1,012 | $2.64 | $3K | 7,672 |
Page 14 of 27 · 521 trades